Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy

Nucl Med Commun. 2013 Oct;34(10):1023. doi: 10.1097/MNM.0b013e32836485b7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 3-Iodobenzylguanidine*
  • Female
  • Humans
  • Male
  • Neuroblastoma / diagnostic imaging*
  • Neuroblastoma / pathology*
  • Radionuclide Imaging
  • Whole Body Imaging / methods*

Substances

  • 3-Iodobenzylguanidine